Search

A new technology that allows researchers to peer inside malignant tumors shows that two experimental drugs can normalize aberrant blood vessels, oxygenation, and other aspects of the tumor microenvironment in non-small cell lung cancer (NSCLC), helping to suppress the tumor’s growth and spread, UT

Blood donation programs represent a unique opportunity as a public health portal to screen for diseases.

UT Southwestern Medical Center has informed affected patients of an inappropriate disclosure of their names and email addresses through the use of a third-party vendor. The vendor was used to send invitations to an event for the Kidney Cancer Program.

A new initiative funded by The University of Texas System and the state of Texas seeks to improve care for trauma patients.

Even though repeated hits to the head are common in professional sports, the long-term effects of concussions are still poorly understood.

Immobilization is the most common treatment, and yet, until recently, it was unknown exactly why this technique worked to advance healing.

– In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center, a short interfering RNA (siRNA) drug directed to tumor cells, ARO-HIF2, effectively disrupted HIF2α, a key driver of clear cell renal cell carcinoma (ccRCC).

Two new UT Southwestern studies published today report some surprising findings: Only half of practicing physicians are registered to vote, and the most common obstacle faced by resident physicians is the lack of time to vote.

Interstitial pneumonia with autoimmune features (IPAF) is a disease with many possible causes and no standard of care, making it particularly difficult to treat. While immunosuppressant drugs are primarily prescribed, they don’t work for all patients.

Blocking a molecule that draws sensory nerves into musculoskeletal injuries prevents heterotopic ossification (HO), a process in which bone abnormally grows in soft tissue during healing